BETHESDA, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (AMEX:RGN; www.regenerx.com) today announced an interview with CEO, J.J. Finkelstein, regarding its recent $9.5 million private financing and product development strategy for 2007. The interview is posted on the Wall Street Reporter Web site, www.wallstreetreporter.com.
